NEW YORK (360Dx) – Diagnostics firm Novacyt today announced it has raised €9.7 million ($11.4 million).

The company raised €4.7 million through a conditional placement of almost 7.1 million shares, and €5.0 million through an unconditional direct subscription of nearly 7.7 million shares. Both had an issue price of 59.38 pence per share.

New UK institutional investors and new and current French institutional investors participated in the raise, Novacyt said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.